171 related articles for article (PubMed ID: 3496934)
1. Upper gastrointestinal findings and faecal occult blood in patients with rheumatic diseases taking nonsteroidal anti-inflammatory drugs.
Collins AJ; Du Toit JA
Br J Rheumatol; 1987 Aug; 26(4):295-8. PubMed ID: 3496934
[TBL] [Abstract][Full Text] [Related]
2. [Endoscopic study of digestive lesions caused by the use of nonsteroidal anti-inflammatory agents in rheumatic patients].
van Linthoudt D; Kocher F; Ott H
Schweiz Med Wochenschr; 1987 Apr; 117(16):604-8. PubMed ID: 3495881
[TBL] [Abstract][Full Text] [Related]
3. Iron deficiency anaemia in patients with rheumatic disease receiving non-steroidal anti-inflammatory drugs: the role of upper gastrointestinal lesions.
Upadhyay R; Torley HI; McKinlay AW; Sturrock RD; Russell RI
Ann Rheum Dis; 1990 Jun; 49(6):359-62. PubMed ID: 2383058
[TBL] [Abstract][Full Text] [Related]
4. Contrasting presentation and findings between patients with rheumatic complaints taking nonsteroidal anti-inflammatory drugs and a general population referred for endoscopy.
Collins AJ; Davies J; Dixon SA
Br J Rheumatol; 1986 Feb; 25(1):50-3. PubMed ID: 3484649
[TBL] [Abstract][Full Text] [Related]
5. [The assessment of the effect of glucocorticosteroid and nonsteroidal anti-inflammatory preparations on the development of an erosive-ulcerative lesion of the gastrointestinal tract in patients with rheumatic diseases].
Karateev AE; Nasonova VA; Murav'ev IuV
Ter Arkh; 1999; 71(2):26-30. PubMed ID: 10222549
[TBL] [Abstract][Full Text] [Related]
6. [Ulcers of the colon in association with nonsteroidal anti-inflammatory drugs (NSAID)--a rare cause of gastrointestinal bleeding? Report of 3 cases].
Schwake L; Schlenker T; Schwake S; Hofmann WJ; Stremmel W
Z Gastroenterol; 2000 Dec; 38(12):957-61. PubMed ID: 11194886
[TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword.
Lichtenstein DR; Syngal S; Wolfe MM
Arthritis Rheum; 1995 Jan; 38(1):5-18. PubMed ID: 7818572
[No Abstract] [Full Text] [Related]
8. [A NSAID-associated alimentary tract disease in patients with rheumatism in Russia].
Karataev AE; Konovalova NN; Litovshenko AA; Lomareva NI; Nemtsov BF; Raskina TA; Peshekhonova LK; Nasonov EL
Klin Med (Mosk); 2005; 83(5):33-8. PubMed ID: 15984580
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic findings in the upper gastrointestinal tract of faecal occult blood-positive, colonoscopy-negative patients.
Hisamuddin K; Mowat NA; Phull PS
Dig Liver Dis; 2006 Jul; 38(7):503-7. PubMed ID: 16522381
[TBL] [Abstract][Full Text] [Related]
10. Management of gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs during the therapy of rheumatic diseases. The rheumatologist's perspective.
Robinson DR
Am J Med; 1988 Feb; 84(2A):1-4. PubMed ID: 3126654
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study.
Singh G; Ramey DR; Morfeld D; Shi H; Hatoum HT; Fries JF
Arch Intern Med; 1996 Jul; 156(14):1530-6. PubMed ID: 8687261
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients.
Stupnicki T; Dietrich K; González-Carro P; Straszak A; Terjung A; Thomas KB; Lühmann R; Fischer R
Digestion; 2003; 68(4):198-208. PubMed ID: 14707396
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal side effects of nonsteroidal anti-inflammatory drugs.
Cryer B; Kimmey MB
Am J Med; 1998 Jul; 105(1B):20S-30S. PubMed ID: 9715831
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory efficacy versus gastrointestinal safety: a dilemma resolved? Introduction.
Bach GL
Scand J Rheumatol Suppl; 1992; 96():5-6. PubMed ID: 1439625
[No Abstract] [Full Text] [Related]
15. Alendronate and risedronate: what you need to know about their upper gastrointestinal tract toxicity.
Baker DE
Rev Gastroenterol Disord; 2002; 2(1):20-33. PubMed ID: 12122976
[TBL] [Abstract][Full Text] [Related]
16. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests.
Rockey DC; Koch J; Cello JP; Sanders LL; McQuaid K
N Engl J Med; 1998 Jul; 339(3):153-9. PubMed ID: 9664091
[TBL] [Abstract][Full Text] [Related]
17. Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases.
Janssen M; Dijkmans BA; van der Sluys FA; van der Wielen JG; Havenga K; Vandenbroucke JP; Lamers CB; Zwinderman AH; Cats A
Br J Rheumatol; 1992 Nov; 31(11):747-52. PubMed ID: 1450796
[TBL] [Abstract][Full Text] [Related]
18. [Upper gastrointestinal tract lesions in rheumatoid arthritis].
Kikuchi M; Sato T; Nakano M; Ozawa T; Yoshida K; Takahashi C; Nakazono K; Murasawa A; Arakawa M
Ryumachi; 1991 Aug; 31(4):374-80. PubMed ID: 1948453
[TBL] [Abstract][Full Text] [Related]
19. Sulindac: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.
Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1978 Aug; 16(2):97-114. PubMed ID: 352667
[No Abstract] [Full Text] [Related]
20. [Gastrointestinal lesions produced by nonsteroidal anti-inflammatory agents: the clinical manifestations, risk factors, physiopathology, prevention and treatment].
Martín de Argila C; Moreira V; Gisbert JP
An Med Interna; 1995 Feb; 12(2):85-96. PubMed ID: 7749017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
